Possible Solutions: Medicine available everywhere!
Adopt laws to ensure transparency on R&D costs
Ensure healthy competition and stop anti-competitive behaviour
Attach conditions to licenses on medicines developed with public money -> currently no guarantee on public return on public investments (PRPI)
Create better and transparent cooperation in negotiations (across countries)
Create awareness about problem -> universities should consider the issue when going into negotiations with pharmaceutical companies
Abolish SPC system -> system is outdated
European patent regulation to avoid national differences (see comparison between the Netherlands, Germany, and Belgium)
Reduce the influence of pharma industry lobbyists
Covid-19 Company Practices (GCCP)
